{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 0,
  "authors": [],
  "bibtex": "https://research.draconitic.com/paper/cst0pts779s3h.bib",
  "cited_by": 0,
  "doi": null,
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705867/?tool=EBI",
  "id": "cst0pts779s3h",
  "issns": [
    "2075-1729"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13705867",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705867/pdf/?tool=EBI",
  "pmcid": "PMC13705867",
  "pmid": null,
  "published": "2026-10-01",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/cst0pts779s3h.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:21:34Z",
      "native_id": "PMC:PMC13705867",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13705867"
    }
  ],
  "subjects": [],
  "title": "Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis (MASLD/MASH) and Cardiovascular Risk: Emerging Therapeutic Strategies at the Interface of Liver and Cardiometabolic Disease",
  "title_text": "Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis (MASLD/MASH) and Cardiovascular Risk: Emerging Therapeutic Strategies at the Interface of Liver and Cardiometabolic Disease",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:21:34Z",
  "url": "https://research.draconitic.com/paper/cst0pts779s3h",
  "venue": "Life (Basel, Switzerland)",
  "versions": []
}